deals
Raising finance for Bourn Hall Clinic
We helped Bourn raise a £3.5 million private equity investment from Mobeus Equity Partners to support the company’s plans for geographic growth.
Transaction trends
Total deal volume for UK life sciences and healthcare transactions valued at less than £100m has on average grown at a rate c.20% each year from 2020-2022, total deal value has also grown on average c.13% each year. Total deal value grew from c.£610m in 2020 to c.£780m, whilst total deal volume has risen from 80 deals in 2020 to 116 deals.
Regulatory changes have also been a major driver of M&A activity in the UK healthcare industry. The recent changes in healthcare policies, such as the move towards integrated care systems, have encouraged healthcare providers to restructure their operations and consolidate their services. These regulatory changes have also opened up new opportunities for M&A activity, such as the acquisition of digital health companies and other innovative start-ups.
Technological advancements have also played a significant role in driving M&A activity. Many healthcare providers are seeking to acquire companies that offer new and innovative technologies to improve patient outcomes and reduce costs. This has led to a number of industry adjacent deals, with healthcare providers acquiring businesses in industries such as medical devices, pharmaceuticals, and digital health.